Literature DB >> 115579

Enhancement of endotoxic shock by N-acetylmuramyl-L-alanyl-(L-seryl)-D-isoglutamine (muramyl dipeptide).

E E Ribi, J L Cantrell, K B Von Eschen, S M Schwartzman.   

Abstract

We described elsewhere that the synergistic antitumor activity of endotoxic extracts from Re mutants of gram-negative bacteria and trehalose mycolate against guinea pig syngeneic line 10 tumor was abrogated after peptide substances accompanying these extracts had been removed. This activity could be restored by combining peptide-free endotoxin either with cell wall skeleton from Bacillus Calmette-Guérin, a polymeric mycolic acid-arabinogalactan-mucopeptide complex, or with a combination of two separate components, trehalose dimycolate and N-acetylmuramyl-L-alanyl-(L-seryl)-D-isoglutamine (MDP). We report here that when a combination of endotoxin (150 microgram) and a mixture of MDP (150 microgram) and trehalose dimycolate (150 microgram) was inoculated into established dermal tumors, a significant number of the animals died, presumably of endotoxic shock. All surviving animals suffered severe but temporary lethargy. When administered alone intradermally in the dose levels tested, none of the components caused severe lethargy or lethality. The lethal effects of 159 microgram of MDP also occurred in combination with relatively weak endotoxic products, such as Pseudomonas vaccine (Pseudogen), and these effects did not depend upon the presence of malignant tissue. Guinea pigs inoculated i.v. were even more susceptible inasmuch as the addition of as little as 6 microgram of MDP to 150 microgram of Pseudogen, itself not lethal, caused the death of 80% of the animals.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 115579

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

1.  Induction of Nod1 and Nod2 intracellular pattern recognition receptors in murine osteoblasts following bacterial challenge.

Authors:  Ian Marriott; Dana M Rati; Samuel H McCall; Susanne L Tranguch
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

Review 2.  The role of Toll-like receptors in CNS response to microbial challenge.

Authors:  Gregory W Konat; Tammy Kielian; Ian Marriott
Journal:  J Neurochem       Date:  2006-08-08       Impact factor: 5.372

3.  Activation of an innate immune response in the schistosome-transmitting snail Biomphalaria glabrata by specific bacterial PAMPs.

Authors:  John T Sullivan; Joseph A Belloir
Journal:  Dev Comp Immunol       Date:  2013-10-08       Impact factor: 3.636

4.  The role of macrophages in LPS-induced lethality and tissue injury.

Authors:  P H Groeneveld; E Claassen; C F Kuper; N Van Rooijen
Journal:  Immunology       Date:  1988-03       Impact factor: 7.397

5.  Two adjuvant-active muramyl dipeptide analogs induce differential production of lymphocyte-activating factor and a factor causing distress in guinea pigs.

Authors:  N E Byars
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

6.  Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture.

Authors:  S Yang; R Tamai; S Akashi; O Takeuchi; S Akira; S Sugawara; H Takada
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

7.  Growing tumors induce hypersensitivity to endotoxin and tumor necrosis factor.

Authors:  J Bartholeyns; M Freudenberg; C Galanos
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

8.  Organ injury and cytokine release caused by peptidoglycan are dependent on the structural integrity of the glycan chain.

Authors:  Anders E Myhre; Jon Fredrik Stuestøl; Maria K Dahle; Gunhild Øverland; Christoph Thiemermann; Simon J Foster; Per Lilleaasen; Ansgar O Aasen; Jacob E Wang
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

9.  Formulation of vaccine adjuvant muramyldipeptides (MDP). 2. The thermal reactivity and pH of maximum stability of MDP compounds in aqueous solution.

Authors:  M F Powell; L C Foster; A R Becker; W Lee
Journal:  Pharm Res       Date:  1988-08       Impact factor: 4.200

10.  Muramyl dipeptide is a powerful potentiator of the antitumor action of various tumor-necrotizing agents.

Authors:  N Bloksma; F M Hofhuis; J M Willers
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.